4.0 Review

Prospects for Minocycline Neuroprotection

期刊

ARCHIVES OF NEUROLOGY
卷 67, 期 12, 页码 1442-1448

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/archneurol.2010.191

关键词

-

资金

  1. National Multiple Sclerosis Society
  2. Roche Foundation for Anemia Research
  3. Feldstein Medical Foundation
  4. Shriners Hospitals for Children
  5. National Institutes of Health [R01 NS059043, R01 ES015988, R01 NS025044]
  6. Plane
  7. Shen
  8. Pleasure
  9. Deng

向作者/读者索取更多资源

Minocycline is a clinically available antibiotic and anti-inflammatory drug that also demonstrates neuroprotective properties in a variety of experimental models of neurological diseases. There have thus far been more than 300 publications on minocycline neuroprotection, including a growing number of human studies. Our objective is to critically review the biological basis and translational potential of this action of minocycline on the nervous system. Arch Neurol. 2010;67(12):1442-1448. Published online August 9, 2010. doi:10.1001/archneurol.2010.191

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据